Cite

    Amat, T. et al. (2018). The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii. Clinical microbiology and infection. pp. 630-634. [Online].